Related Experiment Videos
Mild Thrombocytopenia and the Risk of Post-Partum Hemorrhage
Chen Nahshon1,2, Ilana Grach1,2, Eiman Shalabna2,3
1Department of Obstetrics and Gynecology, Lady Davis Carmel Medical Center, Haifa, Israel.
European Journal of Haematology
|July 26, 2026
Summary
Mild thrombocytopenia (low platelet count) in pregnancy is linked to a higher risk of postpartum hemorrhage (PPH). This finding suggests it may be a useful marker for assessing bleeding risk during childbirth.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Perinatal Medicine
Background:
- Mild thrombocytopenia is a common pregnancy complication.
- Its association with postpartum hemorrhage (PPH) is not well-established.
- Emerging data suggest a potential link to increased bleeding risk.
Purpose of the Study:
- To determine if mild thrombocytopenia independently increases the risk of PPH.
- To evaluate the clinical significance of mild thrombocytopenia in pregnancy.
Main Methods:
- Systematic review and meta-analysis of observational studies.
- Electronic literature search across major databases (MEDLINE, PubMed, Embase, Web of Science, Cochrane Library, ClinicalTrials.gov).
- Inclusion of studies evaluating the association between mild thrombocytopenia and PPH.
Main Results:
- Eight retrospective studies involving 79,126 women were analyzed.
- Mild thrombocytopenia was associated with a significantly increased risk of PPH (OR 1.68).
- Increased risks of blood transfusion and significant hemoglobin decline were also observed.
Conclusions:
- Mild thrombocytopenia is associated with increased PPH risk and related hemorrhagic complications.
- It may serve as a clinically relevant risk marker in peripartum assessment.
- Further prospective studies with standardized PPH definitions are recommended.
Related Concept Videos
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.